Stay updated on ECHO-204 Clinical Trial: Epacadostat + Nivolumab
Sign up to get notified when there's something new on the ECHO-204 Clinical Trial: Epacadostat + Nivolumab page.

Latest updates to the ECHO-204 Clinical Trial: Epacadostat + Nivolumab page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedRevision label updated from v3.2.0 to v3.3.2 on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check18 days agoChange DetectedThe government funding status notice was removed from the page, removing the warning about potential delays in updates.SummaryDifference0.3%

- Check40 days agoChange DetectedNo substantial additions or deletions were detected on the page; the content and layout appear unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check62 days agoChange DetectedCore content updated: a government funding and operating status notice has been added and the version updated to v3.2.0; the prior v3.1.0 tag was removed.SummaryDifference2%

- Check69 days agoChange DetectedUpdate: page version bumped to v3.1.0 and removal of the term 'Ovarian cancer' from the content.SummaryDifference0.1%

- Check83 days agoChange DetectedPage revision updated from v3.0.1 to v3.0.2; the Back to Top element was removed, with no substantive content changes otherwise.SummaryDifference0.1%

Stay in the know with updates to ECHO-204 Clinical Trial: Epacadostat + Nivolumab
Enter your email address, and we'll notify you when there's something new on the ECHO-204 Clinical Trial: Epacadostat + Nivolumab page.